Breast Cancer: Hope in Sight for Improved Tamoxifen Therapy?

Research suggests that an enzyme could become a biomarker of response to tamoxifen therapy.

Related Keywords

France , ,Lyon Cancer Research Center ,France Institute Of Health ,Cancer Research Center ,Medical Research ,Medscape French ,French Edition ,Breast Cancer ,Alignant Breast Neoplasm ,Tamoxifen ,Elective Estrogen Receptor Modulator Serm ,Metastatic Breast Carcinoma ,Cancer ,Alignant Neoplasia ,Arcinoma ,Breast ,Genomics ,Genomic Medicine ,Edicine Genomic ,Estrogen ,Estrogen Therapy ,Biomarker ,Iological Marker ,Aromatase Inhibitor ,Exemestane ,Hormone Therapy ,Receptors ,